Trending...
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- City of Chicago Shares Key Logistical, Safety Information for Upcoming New Year's Eve Celebration
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
FAYETTEVILLE, Ark. - illiNews -- Lineus Medical announces publication of the randomized controlled trial performed at Colorado State University Veterinary Teaching Hospital in the Journal of the American Veterinary Medical Association. The canine study had a total of 367 patients and documented the impact that a new class of peripheral IV breakaway devices had on IV complications in hospitalized dogs. The results of the study found that the use of SafeBreak Vascular Vet, Lineus Medical's break-away device, reduced IV complications by 65%.1 Additionally, the results indicated that SafeBreak use may also limit patient discomfort, owner (client) expense, and staff time devoted to managing IV complications.1
SafeBreak® Vascular Vet is a breakaway device that removes harmful forces from peripheral IV lines. The device is installed between the long IV tubing from the pump, and the patient's IV catheter. When harmful forces are applied to the IV line, SafeBreak separates to protect the patient and the IV line. SafeBreak has been proven to reduce IV complications in both small and large animals2. Lineus Medical sponsored the study to document the impact that SafeBreak has on IV complications rates compared to the standard of care. The study demonstrated that there was a statistically significant reduction in overall IV complications when SafeBreak was used. This included reducing IV-line breakage by 92%, dislodgement by 80%, phlebitis by 86%, and occlusion by 100%.1
More on illi News
"Reducing peripheral IV complications is imperative as it ensures that the patient receives all prescribed treatments in a timely manner, but it also may reduce the risk for venous depletion, reduce client costs, and minimize pain for the dog," said Sydney Simpson, co-author of the study.
Dr. Kristin Zersen, principal investigator and senior study author, adds, "This study highlighted a tremendous clinical benefit where the use of SafeBreak Vascular Vet decreased the overall IV complication rate by 65%. With the cost of replacing an IV around $60 compared to the $6.90 cost to replace SafeBreak, this reduction in complications equates to a significant cost savings to the client.1 Just as important, it reduces the need for IV replacement, which can cause pain and anxiety for our patients."
"We were thrilled that the results from this canine study were so significant. In veterinary medicine, the way procedures and supplies are billed to the pet owner is very straight forward compared to a human hospital. This allowed us to clearly show that reducing IV complications with SafeBreak delivers a direct clinical and financial benefit for patients, clients, and care providers," said Spencer Jones, Founder and Chief Technology Officer at Lineus Medical.
More on illi News
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology designed to help reduce complications associated with a variety of medical tubing, such as feeding tubes, urinary catheters and other medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Twitter, or Instagram.
MKG 0158 Rev 00
References
1. Simpson, S. E., & Zersen, K. M. (2022). Fewer peripheral intravenous catheter complications in hospitalized dogs when force-activated separation devices are used versus not used in a randomized controlled clinical trial. Journal of the American Veterinary Medical Association, 1–6. https://doi.org/10.2460/javma.22.03.0125
2. University of Tennessee Large Animal Study Data on File
SafeBreak® Vascular Vet is a breakaway device that removes harmful forces from peripheral IV lines. The device is installed between the long IV tubing from the pump, and the patient's IV catheter. When harmful forces are applied to the IV line, SafeBreak separates to protect the patient and the IV line. SafeBreak has been proven to reduce IV complications in both small and large animals2. Lineus Medical sponsored the study to document the impact that SafeBreak has on IV complications rates compared to the standard of care. The study demonstrated that there was a statistically significant reduction in overall IV complications when SafeBreak was used. This included reducing IV-line breakage by 92%, dislodgement by 80%, phlebitis by 86%, and occlusion by 100%.1
More on illi News
- Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
- Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
- Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
- Phil Marley Releases Two Music Projects While Seeking Kidney Donor
- Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
"Reducing peripheral IV complications is imperative as it ensures that the patient receives all prescribed treatments in a timely manner, but it also may reduce the risk for venous depletion, reduce client costs, and minimize pain for the dog," said Sydney Simpson, co-author of the study.
Dr. Kristin Zersen, principal investigator and senior study author, adds, "This study highlighted a tremendous clinical benefit where the use of SafeBreak Vascular Vet decreased the overall IV complication rate by 65%. With the cost of replacing an IV around $60 compared to the $6.90 cost to replace SafeBreak, this reduction in complications equates to a significant cost savings to the client.1 Just as important, it reduces the need for IV replacement, which can cause pain and anxiety for our patients."
"We were thrilled that the results from this canine study were so significant. In veterinary medicine, the way procedures and supplies are billed to the pet owner is very straight forward compared to a human hospital. This allowed us to clearly show that reducing IV complications with SafeBreak delivers a direct clinical and financial benefit for patients, clients, and care providers," said Spencer Jones, Founder and Chief Technology Officer at Lineus Medical.
More on illi News
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
- Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
- UK Financial Ltd Launches U.S. Operations Following Delaware Approval
- Author Charlene Wexler Earns International Impact Book Award for We Won't Go Back
- Chicago: Mayor Brandon Johnson Statement On Trump Administration Restricting Housing And Healthcare For LGBTQ+ Community
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology designed to help reduce complications associated with a variety of medical tubing, such as feeding tubes, urinary catheters and other medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Twitter, or Instagram.
MKG 0158 Rev 00
References
1. Simpson, S. E., & Zersen, K. M. (2022). Fewer peripheral intravenous catheter complications in hospitalized dogs when force-activated separation devices are used versus not used in a randomized controlled clinical trial. Journal of the American Veterinary Medical Association, 1–6. https://doi.org/10.2460/javma.22.03.0125
2. University of Tennessee Large Animal Study Data on File
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on illi News
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
- Kanoa Debuts Gluten-Free Filled Cereals, Delivering Bold Flavor & Better Nutrition for Anytime Snac
- Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
- Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
- A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- National Van Lines Delivers Holiday Cheer with Aspire Partnership
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- STLE Launches Travel Grants Program to Support Tribology and Lubrication Engineering Professionals
- Digi 995: Void Run Pushes the Digiverse Into Its Darkest, Fastest Chapter Yet
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles


